Marginal effects of public health measures and COVID-19 disease burden in China: A large-scale modelling study

Author:

Wang ZengmiaoORCID,Wu Peiyi,Wang Lin,Li Bingying,Liu Yonghong,Ge Yuxi,Wang Ruixue,Wang Ligui,Tan HuaORCID,Wu Chieh-Hsi,Laine MarkoORCID,Salje Henrik,Song Hongbin

Abstract

China had conducted some of the most stringent public health measures to control the spread of successive SARS-CoV-2 variants. However, the effectiveness of these measures and their impacts on the associated disease burden have rarely been quantitatively assessed at the national level. To address this gap, we developed a stochastic age-stratified metapopulation model that incorporates testing, contact tracing and isolation, based on 419 million travel movements among 366 Chinese cities. The study period for this model began from September 2022. The COVID-19 disease burden was evaluated, considering 8 types of underlying health conditions in the Chinese population. We identified the marginal effects between the testing speed and reduction in the epidemic duration. The findings suggest that assuming a vaccine coverage of 89%, the Omicron-like wave could be suppressed by 3-day interval population-level testing (PLT), while it would become endemic with 4-day interval PLT, and without testing, it would result in an epidemic. PLT conducted every 3 days would not only eliminate infections but also keep hospital bed occupancy at less than 29.46% (95% CI, 22.73–38.68%) of capacity for respiratory illness and ICU bed occupancy at less than 58.94% (95% CI, 45.70–76.90%) during an outbreak. Furthermore, the underlying health conditions would lead to an extra 2.35 (95% CI, 1.89–2.92) million hospital admissions and 0.16 (95% CI, 0.13–0.2) million ICU admissions. Our study provides insights into health preparedness to balance the disease burden and sustainability for a country with a population of billions.

Funder

Scientific and Technological Innovation 2030 - Major Project of New Generation Artificial Intelligence

National Natural Science Foundation of China

National Key Research and Development Program of China

Beijing Science and Technology Planning Project

Beijing Natural Science Foundation

Beijing Advanced Innovation Program for Land Surface Science

Fundamental Research Funds for the Central Universities

Research on Key Technologies of Plague Prevention and Control in Inner Mongolia Autonomous Region

Research Council of Finland

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modeling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference99 articles.

1. China can prepare to end its zero-COVID policy;J-M Chen;Nat Med,2022

2. Comprehensive large-scale nucleic acid–testing strategies support China’s sustained containment of COVID-19;Z Li;Nat Med,2021

3. Hong Kong’s fifth COVID-19 wave—the worst yet;T. Burki;Lancet Infect Dis,2022

4. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic;X Zhang;Lancet,2022

5. Preliminary Study of the Protectiveness of Vaccination Against the COVID-19 in the Outbreak of VOC Omicron BA.2 —Jilin City, Jilin Province, China, March 3–April 12, 2022;X Fan;China CDC Wkly,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3